U.S. flag

An official website of the United States government

NM_018127.7(ELAC2):c.1698+1G>C AND multiple conditions

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 18, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000490332.1

Allele description [Variation Report for NM_018127.7(ELAC2):c.1698+1G>C]

NM_018127.7(ELAC2):c.1698+1G>C

Gene:
ELAC2:elaC ribonuclease Z 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p12
Genomic location:
Preferred name:
NM_018127.7(ELAC2):c.1698+1G>C
HGVS:
  • NC_000017.11:g.12995939C>G
  • NG_015808.1:g.27126G>C
  • NM_001165962.2:c.1578+1G>C
  • NM_018127.7:c.1698+1G>CMANE SELECT
  • NM_173717.2:c.1695+1G>C
  • NC_000017.10:g.12899256C>G
  • NM_001165962.1:c.1578+1G>C
Links:
dbSNP: rs1085307065
NCBI 1000 Genomes Browser:
rs1085307065
Molecular consequence:
  • NM_001165962.2:c.1578+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_018127.7:c.1698+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_173717.2:c.1695+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Prostate cancer, hereditary, 2 (HPC2)
Identifiers:
MONDO: MONDO:0013872; MedGen: C3539120; Orphanet: 1331; OMIM: 614731
Name:
Combined oxidative phosphorylation defect type 17
Synonyms:
Combined oxidative phosphorylation deficiency 17
Identifiers:
MONDO: MONDO:0014190; MedGen: C3809526; Orphanet: 369913; OMIM: 615440

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000267301Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 18, 2016)
germlinereference population

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
East Asiangermlineunknown1not providednot providednot providednot providedreference population

Citations

PubMed

Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.

Xu J, Zheng SL, Carpten JD, Nupponen NN, Robbins CM, Mestre J, Moses TY, Faith DA, Kelly BD, Isaacs SD, Wiley KE, Ewing CM, Bujnovszky P, Chang B, Bailey-Wilson J, Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB.

Am J Hum Genet. 2001 Apr;68(4):901-11. Epub 2001 Mar 14.

PubMed [citation]
PMID:
11254448
PMCID:
PMC1275644

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center, SCV000267301.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1East Asian1not providednot providedreference population PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

Last Updated: Jun 10, 2023